Nutriband Inc is a biotechnology company focused on the development and commercialization of innovative transdermal drug delivery systems and other advanced technologies for the pharmaceutical and healthcare industries. By leveraging cutting-edge research and proprietary platforms, the company aims to enhance the efficacy and safety of medications, providing solutions that improve patient compliance and therapeutic outcomes. Their product pipeline includes a range of applications, from pain management to the treatment of various medical conditions, reflecting their commitment to advancing healthcare through technology.
Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-expected fourth-quarter loss. Kodiak Sciences posted a quarterly loss of $1.13 per share, compared to market expectations for a loss of 77 cents per share.
Shares of LuxUrban Hotels Inc. (NASDAQ: LUXH) fell sharply during Wednesday’s session after the company issued preliminary fourth-quarter revenue outlook below estimates.
Gainers PainReform Ltd. (NASDAQ: PRFX) shares climbed 103% to $11.67. PainReform recently announced pricing of a $2.7 million concurrent registered direct offering and private placement.
Nutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW), has signed an exclusive manufacturing agreement with Fleur Marché for its CBD and Botanical Patch lines.
According to data from Benzinga Pro, during Q1, Nutriband's (NASDAQ:NTRB) reported sales totaled $477 thousand. Despite a 72.44% increase in earnings, the company posted a loss of $1.04 million.
